Brors, Benedikt
Benedikt Brors
VIAF ID: 2548147270457335700009 ( Personal )
Permalink: http://viaf.org/viaf/2548147270457335700009
Preferred Forms
- 100 0 _ ‡a Benedikt Brors
- 100 1 _ ‡a Brors, Benedikt
4xx's: Alternate Name Forms (4)
5xx's: Related Names (3)
- 510 2 _ ‡a Deutsches Krebsforschungszentrum ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Heidelberg ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Universität Heidelberg ‡b Fakultät für Biowissenschaften ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Alternative pre-mRNA splicing as a source of cancer neoepitopes | |
Analysis of whole-genome sequencing data from ICGC-PanCancer project | |
antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation | |
Assessment of modeling strategies for drug response prediction in cell lines and xenografts | |
Cell type classification for multi-sample multi-condition comparisons in single-cell RNA sequencing data | |
Characterization of telomere content and structure from cancer genome sequencing data | |
Characterization of tumor subpopulations in glioblastoma with single cell transcriptomics | |
Chromosomal clustering of tissue restricted antigens | |
Deciphering the Immune Evolution Landscape of Multiple Myeloma Long-Term Survivors Using Single Cell Genomics | |
Development of a high-throughput CRISPR/Cas9 based fluorescent reporter to study DNA double-strand break repair choices. | |
Erforschung des Nutzens eines NRPS, das ein blaues Pigment herstellt, als Markierungsmethode für maßgeschneiderte NRPs | |
Establishing microfluidics-based drug screening methods to determine drug sensitivities of cancer cells. | |
Evaluation von Modellierungsstrategien für die Vohersage des Wirkstoffansprechens in Zelllinien und Xenotransplantaten. | |
Exploring the Potential of the Human Microbiome for Colorectal and Pancreatic Cancer Screening | |
Exploring the use of a blue pigment-producing NRPS as a tagging method to easily detect engineered NRPs | |
gene expression based method inferring cellular composition of pancreatic ductal adenocarcinoma and its application in stratification analysis | |
Genomic analyses of mutational mechanisms and tumor heterogeneity in B-cell lymphomas | |
Identification of epigenetic T cell traits in murine and human tissues under homeostasis | |
Identification of two novel isoforms of putative ependymoma driving genes by alternative splicing analyses | |
ITCC-P4: Molecular characterization and multi-omics analysis of pediatric patient tumor and Patient-Derived Xenograft (PDX) models for preclinical model selection | |
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories | |
molecular landscape of tumor evolution unter therapy in Glioblastoma multiforme | |
Multi-omics of AML | |
Next-generation personalised medicine for high-risk paediatric cancer patients – the INFORM pilot study | |
Next-Generation Sequencing Analysis of Cell-Free DNA Identifies Actionable Alterations and Genomic Features in Pediatric Cancers | |
Roles of SOX10 in Glioblastoma Stem Cell Plasticity | |
Transcriptomics data analysis from renal fibrosis | |
Transkriptionsfaktor SOX11 ist ein potenzielles Onkogen in malignen peripheren Nervenscheidentumoren und Ewing-Sarkomen | |
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer |